Melike Dönmez Tekin, Atike Pınar Erdoğan, Mustafa Şahbazlar, Mustafa Faraşat, Fatma Seher Pehlivan, Ferhat Ekinci. Durable complete metabolic response to enfortumab vedotin plus pembrolizumab in metastatic upper tract urothelial carcinoma: a case report. // BMC Urology. – 2026. – DOI: 10.1186/s12894-026-02264-5. – URL: https://doi.org/10.1186/s12894-026-02264-5
Melike Dönmez Tekin, Atike Pınar Erdoğan, Mustafa Şahbazlar, Mustafa Faraşat, Fatma Seher Pehlivan, & Ferhat Ekinci (2026). Durable complete metabolic response to enfortumab vedotin plus pembrolizumab in metastatic upper tract urothelial carcinoma: a case report. BMC Urology. https://doi.org/10.1186/s12894-026-02264-5
Melike Dönmez Tekin, et al. “Durable complete metabolic response to enfortumab vedotin plus pembrolizumab in metastatic upper tract urothelial carcinoma: a case report.” BMC Urology, 2026. doi:10.1186/s12894-026-02264-5.
@article{Tekin2026,
title = {Durable complete metabolic response to enfortumab vedotin plus pembrolizumab in metastatic upper tract urothelial carcinoma: a case report},
author = {Tekin, Melike Dönmez and Erdoğan, Atike Pınar and Şahbazlar, Mustafa and Faraşat, Mustafa and Pehlivan, Fatma Seher and Ekinci, Ferhat},
journal = {BMC Urology},
year = {2026},
doi = {10.1186/s12894-026-02264-5},
url = {https://doi.org/10.1186/s12894-026-02264-5}
}